Satellos Bioscience Inc. Opens the Market
Satellos Bioscience Inc. Opens the Market
SOURCE Toronto Stock ExchangeTORONTO, May 15, 2024 /PRNewswire/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation to TSX.
多倫多，2024年5月15日 /PRNewswire/-Satellos Bioscience Inc.（多倫多證券交易所股票代碼：MSCL）（“Satellos” 或 “公司”）聯合創始人兼首席執行官弗蘭克·格里森及其團隊與多倫多證券交易所（TSX）全球創新板塊董事總經理丹尼·利普金一起開放市場並慶祝公司畢業於多倫多證券交易所。
Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. For more information, visit .
Satellos 是一家上市生物技術公司，致力於開發治療退行性肌肉疾病的改善生活的藥物。欲了解更多信息，請訪問。
CNW sponsored announcement. To learn more visit .
CNW 贊助的公告。要了解更多信息，請訪問。
SOURCE Toronto Stock Exchange
來源：多倫多證券交易所